NeuroMetrix Announces Participation in the Center to Stream Healthcare In Place (C2SHIP) as an Industry Partner
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has joined
the Center to Stream Healthcare In Place (C2SHIP) as an industry
C2SHIP is a U.S. National Science Foundation (NSF) funded
consortium of leading academic centers and industry partners with a
mission to develop technologies and approaches for high-quality
personalized healthcare that is delivered at-home. The initial four
participating academic centers are the University of Arizona,
Baylor College of Medicine, University of Southern California and
the California Institute of Technology.
In this collaboration, NeuroMetrix will focus on novel
therapeutic applications of its Quell® wearable neuromodulation
technology and leveraging the information in the Quell Health Cloud
chronic pain database using data science expertise at the
participating academic centers.
“One of the key goals of C2SHIP is accelerating translation of
cutting-edge technologies to patients’ care in-place, while
training students and fellows in remote patient care," said Bijan
Najafi, Ph.D., Professor of Surgery, Director of Clinical Research
at the Division of Vascular Surgery and Director of C2SHIP at the
Baylor College of Medicine. "We are pleased to welcome NeuroMetrix
to C2SHIP as one of our industrial members. NeuroMetrix’s
innovative product called Quell is well suited to the mission of
C2SHIP. We are hoping with the support of C2SHIP that we will
accelerate its integration for the in-place management of chronic
pain, remote monitoring of pain and its impact on mobility, and to
empower patients to select personalized pain management regimes to
better move through the world."
"We are honored to join C2SHIP and look forward to a productive
partnership with the participating academic centers, which are
among the top biomedical research institutions in the country.
Through these collaborations we hope to advance Quell technology to
further benefit patients,” said Shai N. Gozani, M.D., Ph.D.,
President and CEO of NeuroMetrix."
The mission of the Center to Stream Healthcare In Place (C2SHIP)
is to engage academic and industrial partners in joint efforts that
develop healthcare technologies for in-place care and accelerate
innovation through multi-specialty collaborations. The Center's
strategy is to emphasize fundamental investigations that provide an
in-depth understanding of the core disciplines needed for
personalized technology that promotes in-place care, to establish
effective interactions with Center members to promote innovation
capacity and accelerate technology transfer, and to promote
collaborations with other existing centers to create multi-center
innovative technology for the involved core disciplines. C2SHIP is
part of the U.S. National Science Foundation (NSF)
Industry/University Cooperative Research Centers (I/UCRC) program.
For more information visit C2SHIP.org.
NeuroMetrix is an innovation-driven company focused on the
development and global commercialization of non-invasive medical
devices for the diagnosis and treatment of pain and neurological
disorders. The Company has three commercial products. DPNCheck® is
a diagnostic device that provides rapid, point-of-care detection of
peripheral neuropathies. ADVANCE® is a diagnostic device that
provides automated, in-office nerve conduction studies for the
evaluation of entrapment neuropathies. Quell® is a wearable
neurostimulation device indicated for treatment of lower extremity
chronic pain. For more information, visit NeuroMetrix.com.
Source: NeuroMetrix, Inc.Thomas T. HigginsSVP and Chief
Historical Stock Chart
From Dec 2021 to Jan 2022
Historical Stock Chart
From Jan 2021 to Jan 2022